Description
Collavant® n2, developed by Bioiberica and distributed in France by Elementa, illustrates the growing integration of functional nutrition into accessible food formats. It is a native type II collagen whose efficacy has been demonstrated at a daily dose of only 40 mg—an extremely low inclusion level compared to hydrolyzed collagens traditionally used at several grams per day.
This low dosage represents a major competitive advantage for the food industry, freeing up formulation space and facilitating combination with other nutritional ingredients. Collavant® n2 retains its native structure after demanding thermal processes, including pasteurization and UHT treatments, enabling its incorporation into processed food matrices.
Its innovative positioning also lies in its integration into playful food formats, such as functional gummies, reflecting a market shift toward products that combine pleasure, convenience, and scientifically documented nutritional benefits, particularly for mobility and recovery.
